Tekla Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $18.3M | Sell |
|
|||||
|
2023
Q1 | $29.2M | Buy |
|
|||||
|
2022
Q4 | $23.9M | Buy |
|
|||||
|
2022
Q3 | $12.8M | Buy |
|
|||||
|
2022
Q2 | $10.6M | Hold |
|
|||||
|
2022
Q1 | $9.87M | Hold |
|
|||||
|
2021
Q4 | $11.3M | Hold |
|
|||||
|
2021
Q3 | $9.89M | Hold |
|
|||||
|
2021
Q2 | $10.7M | Hold |
|
|||||
|
2021
Q1 | $9.67M | Sell |
|
|||||
|
2020
Q4 | $24.4M | Sell |
|
|||||
|
2020
Q3 | $24.8M | Buy |
|
|||||
|
2020
Q2 | $30.3M | Sell |
|
|||||
|
2020
Q1 | $22.9M | Sell |
|
|||||
|
2019
Q4 | $23.4M | Buy |
|
|||||
|
2019
Q3 | $16.6M | Hold |
|
|||||
|
2019
Q2 | $21.1M | Buy |
|
|||||
|
2019
Q1 | $19.7M | Buy |
|
|||||
|
2018
Q4 | $17.7M | Buy |
|
|||||
|
2018
Q3 | $13.6M | Hold |
|
|||||
|
2018
Q2 | $13.2M | Sell |
|
|||||
|
2018
Q1 | $22.8M | Sell |
|
|||||
|
2017
Q4 | $43.7M | Sell |
|
|||||
|
2017
Q3 | $46.7M | Hold |
|
|||||
|
2017
Q2 | $45.6M | Sell |
|
|||||
|
2017
Q1 | $44.4M | Sell |
|
|||||
|
2016
Q4 | $47.4M | Sell |
|
|||||
|
2016
Q3 | $65.7M | Buy |
|
|||||
|
2016
Q2 | $50.9M | Buy |
|
|||||
|
2016
Q1 | $49.2M | Hold |
|
|||||
|
2015
Q4 | $62.5M | Buy |
|
|||||
|
2015
Q3 | $60.1M | Buy |
|
|||||
|
2015
Q2 | $73.2M | Hold |
|
|||||
|
2015
Q1 | $66.7M | Sell |
|
|||||
|
2014
Q4 | $51.5M | Sell |
|
|||||
|
2014
Q3 | $51.3M | Buy |
|
|||||
|
2014
Q2 | $26.2M | Hold |
|
|||||
|
2014
Q1 | $28.7M | Buy |
|
|||||
|
2013
Q4 | $18.1M | Buy |
|
|||||
|
2013
Q3 | $13.1M | Buy |
|
|||||
|
2013
Q2 | $4.18M | Buy |
|